ECRI Provides Feedback on Proposed Medical Supply Tariffs

ECRI submitted comments in response to the US Trade Representative (USTR)’s solicitation for input on proposed tariffs affecting $18 billion worth of goods manufactured in China, including medical products.

ECRI and the Institute for Safe Medication Practices (ISMP) urged the USTR to carefully consider potential adverse impacts of trade policy on patient safety as it relates to pharmaceuticals, medical devices, and healthcare supplies. The feedback emphasized that patient safety and the uninterrupted supply of health-related products must be prioritized in any policy discussions about trade restrictions and tariffs.

ECRI and ISMP's stance highlights the critical need to ensure the availability of medical products, such as syringes and their accessories, personal protective equipment, and other essential medical supplies.

Download ECRI’s comments on medical supply tariffs

ECRI and ISMP's position underscores the importance of balancing trade policies with the need to maintain a stable supply of critical health products to safeguard public health and ensure that patient care is not compromised.

FOR MORE INFORMATION

Contact Yvonne Rhodes, Associate Director of Strategic Communications, ECRI, yrhodes@ECRI.org

ABOUT ECRI & ISMP

ECRI is a nonprofit organization dedicated to improving the safety, quality, and cost-effectiveness of care across all healthcare settings. Founded in 1968, ECRI conducts research and provides evidence-based solutions and guidance to healthcare organizations, government agencies, and other stakeholders. ECRI is recognized globally for its contributions to healthcare improvement and is often cited as an authoritative source in matters related to patient safety and healthcare technology.

ISMP is a nonprofit organization dedicated to preventing medication errors and improving medication safety. ISMP provides education, consulting, and research to healthcare professionals and organizations to promote safe medication practices. ISMP is known for their work in developing guidelines, best practices, and tools to enhance patient safety related to medication use. ISMP is a wholly owned subsidiary of ECRI.